IBB icon

iShares Biotechnology ETF

431 hedge funds and large institutions have $6B invested in iShares Biotechnology ETF in 2015 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 130 increasing their positions, 152 reducing their positions, and 57 closing their positions.

Holders
431
Holders Change
+17
Holders Change %
+4.11%
% of All Funds
11.32%
Holding in Top 10
32
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+10.34%
% of All Funds
0.84%
New
78
Increased
130
Reduced
152
Closed
57
Calls
$795M
Puts
$1.37B
Net Calls
-$571M
Net Calls Change
+$30.9M
Name Market Value Shares Shares
Change
Shares
Change %
DWA
476
Douglass Winthrop Advisors
New York
-885 Closed
JWM
477
Jackson Wealth Management
Florida
-797 Closed
FIG
478
Fusion Investment Group
Pennsylvania
-587 Closed
HCP
479
Holt Capital Partners
Texas
-540 Closed
JIC
480
Joel Isaacson & Co
New York
-500 Closed
Simplex Trading
481
Simplex Trading
Illinois
-391 Closed
1832 Asset Management
482
1832 Asset Management
Ontario, Canada
-119 Closed
WCM
483
Wealthcare Capital Management
Virginia
-103 Closed
PSI
484
Pinnacle Summer Investments
Virginia
-60 Closed
OFS
485
Orrstown Financial Services
Pennsylvania
-50 Closed
KF
486
Krilogy Financial
Missouri
-48 Closed
WCM
487
Windsor Capital Management
Arizona
-36 Closed
MPWT
488
MassMutual Private Wealth & Trust
Connecticut
-25 Closed
W
489
Wealthfront
California
-17 Closed
PFO
490
Pathstone Family Office
New Jersey
-15 Closed
PVI
491
Pura Vida Investments
New York
Jennison Associates
492
Jennison Associates
New York
ZDA
493
Zweig-DiMenna Associates
New York
HP
494
Hound Partners
New York
MCM
495
MKP Capital Management
New York
CA
496
Continental Advisors
Utah
PC
497
Pomelo Capital
New York
CF
498
CenterStar Fund
Illinois
AFM
499
Anson Funds Management
Texas
GAMA
500
Graticule Asia Macro Advisors
New York